Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GSK2336805 + PEG/RIBA in Chronic HCV Genotype 1 or 4
NCT01648140Phase 2Completed
- Sponsor
- GSK
- Start
- Aug 2012
- Primary completion
- Jul 2014
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 2 trial of GSK2336805 in hepatitis C (HCV), sponsored by GSK. Started Aug 2012; status: completed.
02
Drugs
GSK2336805
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT01648140.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01648140.